Cargando…
HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation
BACKGROUND: Laryngeal cancer is a common malignancy of the head and neck, it’s important to find novel targets for its therapy. The 5-hydroxytryptamine receptor 7 (HTR7) belongs to the G protein-coupled receptors (GPCRs) family which are easily druggable in diseases; however, its role in laryngeal c...
Autores principales: | Sheng, Xiaoli, Liu, Wenlin, Lu, Zhongming, Xu, Mimi, Li, Rui, Zhong, Rong, Li, Yunxian, Liu, Tao, Zhang, Siyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184477/ https://www.ncbi.nlm.nih.gov/pubmed/34164474 http://dx.doi.org/10.21037/atm-21-1069 |
Ejemplares similares
-
Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway
por: Liu, Wenlin, et al.
Publicado: (2021) -
PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
por: Sheng, Xiaoli, et al.
Publicado: (2019) -
Erratum to HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation
Publicado: (2022) -
Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation
por: Li, Rui, et al.
Publicado: (2020) -
TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
por: Jiang, Liang, et al.
Publicado: (2017)